SAREPTA THERAPEUTICS, INC. Unbilled Receivables, Current
SAREPTA THERAPEUTICS, INC. (SRPT) had Unbilled Receivables, Current of $929.00 thousand as of 2017-03-31, per its 10-Q filed 2017-05-04.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:UnbilledReceivablesCurrent · last filed 2017-05-04
- 2017-03-31: Unbilled Receivables, Current $929.00K.
- 2016-12-31: Unbilled Receivables, Current $1.23M.
- 2015-12-31: Unbilled Receivables, Current $3.98M.
| Period end | Unbilled Receivables, Current |
|---|---|
| 2017-03-31 | $929.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $1.23M 10-Q · filed 2017-05-04 |
| 2015-12-31 | $3.98M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |